Wednesday, September 16, 2026Latest filing Sep 14, 2026

Brad Knott Periodic Transaction Report

Filed Feb 25, 2025 · House Clerk · 3 transactions

U.S. Representative · R · NC-13 · All trades by Brad Knott

On February 25, 2025, Rep. Brad Knott (R-NC-13) filed a periodic transaction report with the House Clerk disclosing 3 transactions (2 purchases, 1 sale) dated Jan 10, 2025 through Jan 14, 2025.

The filing covers 2 tickers, including $CMPO, $ORMP.

Reported amount ranges sum to $17K–$80K. Congress reports trade sizes in ranges, not exact figures.

2 trades were reported more than 45 days after the trade date, outside the STOCK Act's 45-day window. The longest lag in this filing was 46 days.

Source document: House Clerk filing 20027846

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Brad Knott · Sold $ORMP · Jan 10 · $15K–$50K

0.28LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.50
Cluster activityx 0.150.00
Track recordx 0.350.38

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Brad Knott

Get an email the moment Brad Knott files the next one. Free, no card, no spam.

Follow free →
3
Transactions
2 / 1
Buys / sells
2
Tickers
46d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Jan 10, 2025CMPOCompoSecure, Inc. - Class A Common Stock (CMPO)buySelf$1K–$15K46d
Jan 10, 2025ORMPOramed Pharmaceuticals Inc. - Common Stock (ORMP)sellSelf$15K–$50K46d
Jan 14, 2025CMPOCompoSecure, Inc. - Class A Common Stock (CMPO)buySelf$1K–$15K42d

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →